Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.150
+0.060 (2.87%)
Jul 1, 2025, 10:54 AM - Market open
Humacyte Stock Forecast
HUMA's stock price has decreased by -56.15% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts that cover Humacyte stock have a consensus rating of "Strong Buy" and an average price target of $13, which forecasts a 504.65% increase in the stock price over the next year. The lowest target is $4 and the highest is $25.
Price Target: $13 (+504.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 6 | 6 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,062.79% | Jun 9, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +86.05% | May 14, 2025 |
Benchmark | Benchmark | Strong Buy Maintains $17 → $14 | Strong Buy | Maintains | $17 → $14 | +551.16% | May 14, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,062.79% | May 13, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,062.79% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
8.15M
Revenue Next Year
81.21M
from 8.15M
Increased by 896.45%
EPS This Year
-0.32
from -1.26
EPS Next Year
-0.33
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.3M | 308.0M | 171.7M | ||
Avg | 8.2M | 81.2M | 105.4M | ||
Low | 3.3M | 26.5M | 74.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 3,678.5% | 111.4% | ||
Avg | - | 896.5% | 29.7% | ||
Low | - | 224.7% | -8.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.16 | 0.89 | 2.32 | ||
Avg | -0.32 | -0.33 | 0.26 | ||
Low | -0.70 | -0.80 | -0.34 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.